Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF by Patrick A. Kwaah, MBChB, Samuel A. Mensah, MBChB, Abraham Carboo, MBChB, MPH, Hamza A. Rashid, MBBS, Emmanuel A. Agyemang, MBChB, Grace Appah, MBChB, Smith K. Frimpong, MD

Get full text